药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Podofilox
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Pazopanib.
Podofilox
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Pazopanib.
Podofilox
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Pazopanib.
Podofilox
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Pazopanib.
Podofilox
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Pazopanib.
Podofilox
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Pazopanib.
Podofilox
Vernakalant
The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Pazopanib.
Podofilox
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Pazopanib.
Podofilox
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Pazopanib.
Podofilox
Celiprolol
The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Pazopanib.
Podofilox
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Pazopanib.
Podofilox
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Pazopanib.
Podofilox
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Pazopanib.
Podofilox
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Pazopanib.
Podofilox
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Pazopanib.
Podofilox
Arformoterol
The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Pazopanib.
Podofilox
Alimemazine
The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Pazopanib.
Podofilox
Sevoflurane
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Pazopanib.
Podofilox
Encainide
The risk or severity of QTc prolongation can be increased when Encainide is combined with Pazopanib.
Podofilox
Desflurane
The risk or severity of QTc prolongation can be increased when Desflurane is combined with Pazopanib.